Immuron Ltd (IMC) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Immuron Ltd (IMC) has a cash flow conversion efficiency ratio of -0.256x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$-2.06 Million ≈ $-1.46 Million USD) by net assets (AU$8.07 Million ≈ $5.71 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Immuron Ltd - Cash Flow Conversion Efficiency Trend (2001–2025)
This chart illustrates how Immuron Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read Immuron Ltd (IMC) financial obligations for a breakdown of total debt and financial obligations.
Immuron Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Immuron Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Effnetplattformen Holding AB
ST:EFFH
|
-0.009x |
|
East Side Games Group Inc
TO:EAGR
|
-0.032x |
|
LEHNER INVESTMENTS AG
F:LEH
|
N/A |
|
Diriteks Dirilis Tekstil Sanayi ve Ticaret AS
IS:DIRIT
|
-0.030x |
|
Linkage Global Inc Ordinary Shares
NASDAQ:LGCB
|
-0.187x |
|
Total Telcom Inc
V:TTZ
|
0.033x |
|
Horizon Petroleum Ltd
V:HPL
|
0.023x |
|
XP Power Ltd
LSE:XPP
|
0.040x |
Annual Cash Flow Conversion Efficiency for Immuron Ltd (2001–2025)
The table below shows the annual cash flow conversion efficiency of Immuron Ltd from 2001 to 2025. For the full company profile with market capitalisation and key ratios, see IMC company net worth.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-06-30 | AU$8.07 Million ≈ $5.71 Million |
AU$-6.14 Million ≈ $-4.34 Million |
-0.761x | -64.39% |
| 2024-06-30 | AU$12.71 Million ≈ $8.99 Million |
AU$-5.88 Million ≈ $-4.16 Million |
-0.463x | -264.71% |
| 2023-06-30 | AU$19.62 Million ≈ $13.88 Million |
AU$-2.49 Million ≈ $-1.76 Million |
-0.127x | +6.13% |
| 2022-06-30 | AU$23.18 Million ≈ $16.40 Million |
AU$-3.13 Million ≈ $-2.22 Million |
-0.135x | +14.30% |
| 2021-06-30 | AU$25.90 Million ≈ $18.32 Million |
AU$-4.08 Million ≈ $-2.89 Million |
-0.158x | +71.88% |
| 2020-06-30 | AU$5.64 Million ≈ $3.99 Million |
AU$-3.16 Million ≈ $-2.24 Million |
-0.561x | -129.19% |
| 2019-06-30 | AU$7.35 Million ≈ $5.20 Million |
AU$-1.80 Million ≈ $-1.27 Million |
-0.245x | +41.08% |
| 2018-06-30 | AU$8.44 Million ≈ $5.97 Million |
AU$-3.50 Million ≈ $-2.48 Million |
-0.415x | +61.17% |
| 2017-06-30 | AU$6.57 Million ≈ $4.65 Million |
AU$-7.03 Million ≈ $-4.97 Million |
-1.069x | -2.42% |
| 2016-06-30 | AU$4.94 Million ≈ $3.50 Million |
AU$-5.16 Million ≈ $-3.65 Million |
-1.044x | -66.26% |
| 2015-06-30 | AU$4.81 Million ≈ $3.40 Million |
AU$-3.02 Million ≈ $-2.14 Million |
-0.628x | -60.80% |
| 2014-06-30 | AU$6.79 Million ≈ $4.80 Million |
AU$-2.65 Million ≈ $-1.88 Million |
-0.391x | +97.23% |
| 2013-06-30 | AU$144.99K ≈ $102.59K |
AU$-2.05 Million ≈ $-1.45 Million |
-14.108x | -1074.35% |
| 2012-06-30 | AU$2.05 Million ≈ $1.45 Million |
AU$-2.46 Million ≈ $-1.74 Million |
-1.201x | -5.67% |
| 2011-06-30 | AU$1.73 Million ≈ $1.23 Million |
AU$-1.97 Million ≈ $-1.39 Million |
-1.137x | -69.19% |
| 2010-06-30 | AU$3.36 Million ≈ $2.38 Million |
AU$-2.26 Million ≈ $-1.60 Million |
-0.672x | -105.99% |
| 2009-06-30 | AU$-184.87K ≈ $-130.81K |
AU$-2.07 Million ≈ $-1.47 Million |
11.209x | +699.89% |
| 2008-06-30 | AU$1.11 Million ≈ $785.58K |
AU$-2.07 Million ≈ $-1.47 Million |
-1.868x | -23.80% |
| 2007-06-30 | AU$1.98 Million ≈ $1.40 Million |
AU$-2.99 Million ≈ $-2.12 Million |
-1.509x | -181.71% |
| 2006-06-30 | AU$5.24 Million ≈ $3.71 Million |
AU$-2.81 Million ≈ $-1.99 Million |
-0.536x | -112.46% |
| 2005-06-30 | AU$6.96 Million ≈ $4.93 Million |
AU$-1.76 Million ≈ $-1.24 Million |
-0.252x | +16.78% |
| 2004-06-30 | AU$4.08 Million ≈ $2.89 Million |
AU$-1.24 Million ≈ $-874.24K |
-0.303x | +0.21% |
| 2002-06-30 | AU$6.32 Million ≈ $4.47 Million |
AU$-1.92 Million ≈ $-1.36 Million |
-0.304x | -36.77% |
| 2001-06-30 | AU$7.48 Million ≈ $5.29 Million |
AU$-1.66 Million ≈ $-1.17 Million |
-0.222x | -- |
About Immuron Ltd
Immuron Limited, a biopharmaceutical company, engages in the research, development, and commercialization of polyclonal antibodies in Australia, the United States, and Canada. It operates through two segments, Research and Development; and Hyper-immune Products. The company offers Travelan, an over-the-counter medicine to reduce the risk of travelers' diarrhea and risk of minor gastrointestinal d… Read more